BRINGHEN, Sara
 Distribuzione geografica
Continente #
NA - Nord America 2.179
EU - Europa 1.163
AS - Asia 596
SA - Sud America 41
AF - Africa 37
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.046
Nazione #
US - Stati Uniti d'America 2.123
IT - Italia 431
DE - Germania 268
CN - Cina 198
JP - Giappone 119
GB - Regno Unito 117
IN - India 78
FR - Francia 62
KR - Corea 60
VN - Vietnam 49
CA - Canada 45
PL - Polonia 36
ES - Italia 35
CZ - Repubblica Ceca 28
SE - Svezia 26
NL - Olanda 24
AU - Australia 23
ZA - Sudafrica 21
AT - Austria 20
HK - Hong Kong 19
TR - Turchia 19
CH - Svizzera 14
IE - Irlanda 14
RU - Federazione Russa 13
CO - Colombia 12
BR - Brasile 10
DK - Danimarca 9
HU - Ungheria 9
IL - Israele 9
AR - Argentina 8
BE - Belgio 8
MX - Messico 8
SG - Singapore 8
DZ - Algeria 7
GR - Grecia 7
NO - Norvegia 6
NZ - Nuova Zelanda 6
PK - Pakistan 6
PT - Portogallo 6
UA - Ucraina 6
CL - Cile 5
ID - Indonesia 5
PE - Perù 5
RO - Romania 5
TN - Tunisia 5
FI - Finlandia 4
HR - Croazia 4
JO - Giordania 4
LT - Lituania 4
SA - Arabia Saudita 4
TW - Taiwan 4
IQ - Iraq 3
MK - Macedonia 3
QA - Qatar 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
EG - Egitto 2
SI - Slovenia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BG - Bulgaria 1
EU - Europa 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
MA - Marocco 1
MG - Madagascar 1
PH - Filippine 1
VE - Venezuela 1
Totale 4.046
Città #
Fairfield 251
Cambridge 140
Houston 134
Santa Cruz 116
Woodbridge 115
Ashburn 108
Seattle 97
Buffalo 94
Ann Arbor 76
Torino 76
Turin 65
Wilmington 51
Fleming Island 42
Dong Ket 38
Beijing 37
Tokyo 32
Nürnberg 31
Pinerolo 31
Chicago 28
New York 27
San Diego 27
Rome 20
Duncan 19
Muizenberg 18
Vienna 18
Warsaw 18
Raritan 17
Seoul 17
Boardman 16
London 16
Pisa 16
Nanjing 15
Brooklyn 14
Clearwater 14
Dublin 14
Guangzhou 14
Shanghai 14
Norwalk 13
Stockholm 13
University Park 13
Leawood 12
Los Angeles 11
Madison 10
Milan 10
Orlando 10
Bengaluru 9
Chennai 9
Dallas 9
Hamburg 9
Ottawa 9
Paris 9
Rochester 9
Athens 8
Changsha 8
Las Vegas 8
Phoenix 8
San Jose 8
Sanayi 8
Seocho 8
Toronto 8
Wuhan 8
Changchun 7
Henderson 7
Lake Forest 7
Milpitas 7
Mountain View 7
Ontario 7
Sydney 7
Berlin 6
Budapest 6
Des Moines 6
Hangzhou 6
Hyderabad 6
Lanzhou 6
Providence 6
Provo 6
Atlanta 5
Auckland 5
Baltimore 5
Bologna 5
Central 5
Chengdu 5
Denver 5
Dorking 5
Frankfurt am Main 5
Gillette 5
Honolulu 5
Istanbul 5
Kyoto 5
Leihgestern 5
Limoges 5
Madrid 5
Messina 5
Mumbai 5
Munich 5
Pittsburgh 5
Portland 5
San Francisco 5
Taunusstein 5
Tel Aviv 5
Totale 2.320
Nome #
A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma, file e27ce42a-e94a-2581-e053-d805fe0acbaa 525
Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma, file e27ce428-83bb-2581-e053-d805fe0acbaa 446
Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study., file e27ce427-a38f-2581-e053-d805fe0acbaa 307
A Simple Score, Based On Geriatric Assessment, Improves Prediction of Survival, and Risk Of Serious Adverse Events In Elderly Newly Diagnosed Multiple Myeloma Patients, file e27ce42a-ee98-2581-e053-d805fe0acbaa 222
Pharmacokinetic evaluation of pomalidomide for the treatment of myeloma, file e27ce430-af99-2581-e053-d805fe0acbaa 213
Once-weekly carfilzomib, pomalidomide, and low-dose dexamethasone for relapsed/refractory myeloma: a phase I/II study, file e27ce435-83b6-2581-e053-d805fe0acbaa 192
Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: Results from a Gruppo Italiano Malattie EMatologiche dell'Adulto Multiple Myeloma Working Party study, file e27ce427-7c64-2581-e053-d805fe0acbaa 157
Lenalidomide maintenance after autologous stem-cell transplantation in newly diagnosed multiple myeloma: A meta-analysis, file e27ce42f-8645-2581-e053-d805fe0acbaa 152
Does low-molecular-weight heparin influence the antimyeloma effects of thalidomide? A retrospective analysis of data from the GIMEMA, nordic and turkish myeloma study groups, file e27ce427-8421-2581-e053-d805fe0acbaa 150
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group, file e27ce42f-8b46-2581-e053-d805fe0acbaa 140
Impact of New Drugs on the Long-Term Follow-Up of Upfront Tandem Autograft-Allograft in Multiple Myeloma, file e27ce42c-91d4-2581-e053-d805fe0acbaa 137
Emerging drugs and combinations to treat multiple myeloma, file e27ce430-f3b6-2581-e053-d805fe0acbaa 117
European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications, file e27ce427-76e7-2581-e053-d805fe0acbaa 96
Cardiovascular adverse events in modern myeloma therapy - Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA), file e27ce42d-5d05-2581-e053-d805fe0acbaa 92
Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network, file e27ce431-3459-2581-e053-d805fe0acbaa 90
Geriatric assessment predicts survival and toxicities in elderly myeloma patients: An International Myeloma Working Group report, file e27ce427-b676-2581-e053-d805fe0acbaa 85
Patient-centered practice in elderly myeloma patients: an overview and consensus from the European Myeloma Network (EMN), file e27ce435-99a2-2581-e053-d805fe0acbaa 83
Current Phase II investigational proteasome inhibitors for the treatment of multiple myeloma, file e27ce430-925f-2581-e053-d805fe0acbaa 70
Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study., file e27ce427-e241-2581-e053-d805fe0acbaa 58
Monoclonal antibodies to treat multiple myeloma: A dream come true, file e27ce431-d5bc-2581-e053-d805fe0acbaa 55
Clinical and pharmacologic features of monoclonal antibodies and checkpoint blockade therapy in multiple myeloma, file 185097a3-5f0f-4eca-ba69-26ed618f2ebd 49
Early mortality in myeloma patients treated with first-generation novel agents thalidomide, lenalidomide, bortezomib at diagnosis: A pooled analysis, file e27ce435-863a-2581-e053-d805fe0acbaa 49
Multiple myeloma patients undergoing carfilzomib: Development and validation of a risk score for cardiovascular adverse events prediction, file e27ce431-dbd0-2581-e053-d805fe0acbaa 48
The role of monoclonal antibodies in the first-line treatment of transplant-ineligible patients with newly diagnosed multiple myeloma, file e27ce432-06fe-2581-e053-d805fe0acbaa 43
Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age >80 in the IMWG frailty score, file e27ce431-d76d-2581-e053-d805fe0acbaa 42
Melflufen: A Peptide-Drug Conjugate for the Treatment of Multiple Myeloma, file e27ce431-52f2-2581-e053-d805fe0acbaa 41
Treatment of newly diagnosed elderly multiple myeloma, file e27ce435-7ca7-2581-e053-d805fe0acbaa 37
Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension, file a80eb078-016b-45f2-b47c-8f0139cbeb1c 34
Determining treatment intensity in elderly patients with multiple myeloma, file e27ce435-9705-2581-e053-d805fe0acbaa 31
Effects of Carfilzomib Therapy on Left Ventricular Function in Multiple Myeloma Patients, file e27ce431-df1e-2581-e053-d805fe0acbaa 29
Ultra-Low-Dose Whole-Body Computed Tomography Protocol Optimization for Patients With Plasma Cell Disorders: Diagnostic Accuracy and Effective Dose Analysis From a Reference Center, file e27ce434-dfdd-2581-e053-d805fe0acbaa 29
Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients: updated results of the EMN01 randomized trial, file e27ce432-1245-2581-e053-d805fe0acbaa 28
How is patient care for multiple myeloma advancing?, file e27ce435-a035-2581-e053-d805fe0acbaa 26
Impact of New Drugs on the Long-Term Follow-Up of Upfront Tandem Autograft-Allograft in Multiple Myeloma, file e27ce42c-9e99-2581-e053-d805fe0acbaa 25
A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma, file 489a1238-a926-41d6-a0aa-7120055380bb 16
European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications, file e27ce432-5582-2581-e053-d805fe0acbaa 16
Ixazomib-based induction regimens plus ixazomib maintenance in transplant-ineligible, newly diagnosed multiple myeloma: the phase II, multi-arm, randomized UNITO-EMN10 trial, file e27ce434-dda5-2581-e053-d805fe0acbaa 16
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing, file e27ce435-6515-2581-e053-d805fe0acbaa 14
Lenalidomide and low-dose dexamethasone (Rd) versus bortezomib, melphalan, prednisone (VMP) in elderly newly diagnosed multiple myeloma patients: A comparison of two prospective trials, file e27ce435-88a9-2581-e053-d805fe0acbaa 14
Carfilzomib, cyclophosphamide and dexamethasone for newly diagnosed, high-risk myeloma patients not eligible for transplant: a pooled analysis of two studies, file e27ce435-4d75-2581-e053-d805fe0acbaa 13
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing, file a4e97a93-3d82-4aaa-b92d-85fef843542e 12
Safety of Rapid Daratumumab Infusion: A Retrospective, Multicenter, Real-Life Analysis on 134 Patients With Multiple Myeloma, file e27ce435-2fcf-2581-e053-d805fe0acbaa 12
Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial, file e27ce435-83f3-2581-e053-d805fe0acbaa 12
European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications, file e27ce428-a199-2581-e053-d805fe0acbaa 11
First-line therapy with either bortezomib-melphalan-prednisone or lenalidomide-dexamethasone followed by lenalidomide for transplant-ineligible multiple myeloma patients: a pooled analysis of two randomized trials, file e27ce431-2e53-2581-e053-d805fe0acbaa 11
Salvage therapy in first relapse: a retrospective study in a large patient population with multiple myeloma, file e27ce435-8204-2581-e053-d805fe0acbaa 11
Clinical and pharmacologic features of monoclonal antibodies and checkpoint blockade therapy in multiple myeloma, file e27ce435-4081-2581-e053-d805fe0acbaa 10
Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials, file e27ce435-516c-2581-e053-d805fe0acbaa 10
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing, file e27ce431-1142-2581-e053-d805fe0acbaa 7
Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma, file 37a6a934-f6f7-48fb-943b-31968b6436ec 5
Clinical and pharmacologic features of monoclonal antibodies and checkpoint blockade therapy in multiple myeloma, file e27ce432-2dad-2581-e053-d805fe0acbaa 5
Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma, file e27ce435-4969-2581-e053-d805fe0acbaa 5
Treatment of newly diagnosed elderly multiple myeloma, file e27ce435-7b03-2581-e053-d805fe0acbaa 5
Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma, file e27ce435-852f-2581-e053-d805fe0acbaa 5
A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma, file e27ce431-17eb-2581-e053-d805fe0acbaa 4
Once-weekly carfilzomib, pomalidomide, and low-dose dexamethasone for relapsed/refractory myeloma: a phase I/II study, file e27ce435-5623-2581-e053-d805fe0acbaa 4
A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma, file e27ce435-602e-2581-e053-d805fe0acbaa 4
Efficacy and safety of once-weekly bortezomib in multiple myeloma patients., file e27ce435-7f6c-2581-e053-d805fe0acbaa 4
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review, file f50cdee7-b492-428c-9d8c-bc18fb5b65ed 4
Lenalidomide and low-dose dexamethasone for newly diagnosed primary plasma cell leukemia., file e27ce430-d1fc-2581-e053-d805fe0acbaa 3
Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma, file e27ce431-d75d-2581-e053-d805fe0acbaa 3
Melphalan and its role in the management of patients with multiple myeloma, file e27ce431-e0d0-2581-e053-d805fe0acbaa 3
Melphalan, prednisone, and thalidomide versus thalidomide, dexamethasone, and pegylated liposomal doxorubicin regimen in very elderly patients with multiple myeloma: a case-match study., file e27ce435-407b-2581-e053-d805fe0acbaa 3
Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension, file e27ce435-889d-2581-e053-d805fe0acbaa 3
Once-weekly versus twice-weekly carfilzomib in patients with newly diagnosed multiple myeloma: A pooled analysis of two phase i/ii studies, file 52f0f584-8fc9-4d40-b3a7-b5b1fd8b1d9a 2
A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma, file 5c9d2b60-09e0-49eb-9c2c-ee2f867045f5 2
Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survival., file 7876b7fe-744b-406a-b066-f42213a05937 2
Approach to the Older Adult With Multiple Myeloma, file e27ce42f-6c47-2581-e053-d805fe0acbaa 2
Patient-centered practice in elderly myeloma patients: an overview and consensus from the European Myeloma Network (EMN), file e27ce431-da1d-2581-e053-d805fe0acbaa 2
Geriatric assessment predicts survival and toxicities in elderly myeloma patients: An International Myeloma Working Group report, file e27ce432-5da3-2581-e053-d805fe0acbaa 2
Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survival., file e27ce435-2e47-2581-e053-d805fe0acbaa 2
Lenalidomide-prednisone induction followed by lenalidomide-melphalan-prednisone consolidation and lenalidomide-prednisone maintenance in newly diagnosed elderly unfit myeloma patients., file e27ce435-7965-2581-e053-d805fe0acbaa 2
Salvage therapy in first relapse: a retrospective study in a large patient population with multiple myeloma, file e27ce435-813e-2581-e053-d805fe0acbaa 2
Lenalidomide and low-dose dexamethasone (Rd) versus bortezomib, melphalan, prednisone (VMP) in elderly newly diagnosed multiple myeloma patients: A comparison of two prospective trials, file e27ce435-a4cd-2581-e053-d805fe0acbaa 2
A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma, file 0535c2ac-4a44-4200-b69d-f7ea162511a0 1
Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension, file 2acccf7c-84a6-44fd-b2c8-acb3c9edbe06 1
A Simple Score, Based On Geriatric Assessment, Improves Prediction of Survival, and Risk Of Serious Adverse Events In Elderly Newly Diagnosed Multiple Myeloma Patients, file 511a3b81-6d68-4c62-b08c-c0671d9e6604 1
A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma, file 83fd1b50-5e9e-43f2-b97b-386e3da945b1 1
A Simple Score, Based On Geriatric Assessment, Improves Prediction of Survival, and Risk Of Serious Adverse Events In Elderly Newly Diagnosed Multiple Myeloma Patients, file 9a9ba6f8-e801-4727-8992-21f9a950f3fc 1
Maintenance Treatment and Survival in Patients With Myeloma A Systematic Review and Network Meta-analysis, file e27ce42f-4889-2581-e053-d805fe0acbaa 1
Evaluation of Cardiovascular Toxicity Associated with Treatments Containing Proteasome Inhibitors in Multiple Myeloma Therapy, file e27ce42f-5414-2581-e053-d805fe0acbaa 1
Monoclonal antibodies currently in Phase II and III trials for multiple myeloma, file e27ce431-3078-2581-e053-d805fe0acbaa 1
Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma, file e27ce432-5f85-2581-e053-d805fe0acbaa 1
Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma, file e27ce435-a357-2581-e053-d805fe0acbaa 1
A Simple Score, Based On Geriatric Assessment, Improves Prediction of Survival, and Risk Of Serious Adverse Events In Elderly Newly Diagnosed Multiple Myeloma Patients, file f34301c1-813b-4257-959b-74733bc7db02 1
Totale 4.174
Categoria #
all - tutte 5.805
article - articoli 0
book - libri 0
conference - conferenze 280
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.085


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019320 0 0 11 20 14 8 16 42 33 59 70 47
2019/2020542 42 31 33 72 44 44 57 47 70 26 39 37
2020/2021757 40 47 66 47 49 98 75 62 35 76 59 103
2021/20221.091 112 64 69 104 88 41 155 46 53 55 163 141
2022/20231.120 49 64 178 129 104 83 113 141 98 88 62 11
2023/202466 22 31 13 0 0 0 0 0 0 0 0 0
Totale 4.174